 Connection
James Falko to Female
This is a "connection" page, showing publications James Falko has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.131 |
|
|
|
-
Barker BJ, Goodenough RR, Falko JM. Fenofibrate monotherapy induced rhabdomyolysis. Diabetes Care. 2003 Aug; 26(8):2482-3.
Score: 0.009
-
Cirillo RL, Pozderac RV, Caniano DA, Falko JM. Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule. Clin Nucl Med. 1998 Jun; 23(6):345-9.
Score: 0.006
-
Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab. 1997 Oct; 82(10):3421-4.
Score: 0.006
-
Glueck CJ, Streicher P, Wang P, Sprecher D, Falko JM. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition. 1996 Mar; 12(3):202-5.
Score: 0.005
-
Matney K, Berg M, Falko JM, Draper NL. The role of lipoprotein(a) in clotting reactions during lipoprotein apheresis--A case report. J Clin Lipidol. 2016 Mar-Apr; 10(2):438-42.
Score: 0.005
-
Cottrell DA, Bello FA, Falko JM. 17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronism. Am J Med Sci. 1990 Dec; 300(6):380-2.
Score: 0.004
-
Chevinsky AH, Minton JP, Falko JM. Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg. 1990 Jul; 125(7):935-8.
Score: 0.004
-
Snow R, Ruane J, LaLonde M, Shaffer L, Kim B, Graffagnino C, Falko J, Spencer K, Caulin-Glaser T. Randomized trial assessing the impact of a musculoskeletal intervention for pain before participating in a weight management program. J Cardiopulm Rehabil Prev. 2010 May-Jun; 30(3):173-80.
Score: 0.004
-
La Londe MA, Graffagnino CL, Falko JM, Snow RJ, Spencer K, Caulin-Glaser T. Effect of a weight management program on the determinants and prevalence of metabolic syndrome. Obesity (Silver Spring). 2008 Mar; 16(3):637-42.
Score: 0.003
-
Falko JM, Parr JH, Simpson RN, Wynn V. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med. 1987 Oct; 83(4):641-7.
Score: 0.003
-
Trapnell BC, Mavko LE, Birskovich LM, Falko JM. Metoclopramide suppositories in the treatment of diabetic gastroparesis. Arch Intern Med. 1986 Nov; 146(11):2278-9.
Score: 0.003
-
Meis SB, Snow R, Lalonde M, Falko J, Caulin-Glaser T. A systematic approach to improve lipids in coronary artery disease patients participating in a cardiac rehabilitation program. J Cardiopulm Rehabil. 2006 Nov-Dec; 26(6):355-60; quiz 361-2.
Score: 0.003
-
Osei K, Holland G, Falko JM. Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med. 1986 Oct; 146(10):1973-7.
Score: 0.003
-
Osei K, Weber PA, Falko JM. Coexistence of diabetes mellitus, optic atrophy, and sensorineural deafness: case report. Ann Ophthalmol. 1986 May; 18(5):196-8.
Score: 0.003
-
Graffagnino CL, Falko JM, La Londe M, Schaumburg J, Hyek MF, Shaffer LE, Snow R, Caulin-Glaser T. Effect of a community-based weight management program on weight loss and cardiovascular disease risk factors. Obesity (Silver Spring). 2006 Feb; 14(2):280-8.
Score: 0.003
-
Hindman L, Falko JM, LaLonde M, Snow R, Caulin-Glaser T. Clinical profile and outcomes of diabetic and nondiabetic patients in cardiac rehabilitation. Am Heart J. 2005 Nov; 150(5):1046-51.
Score: 0.003
-
Caulin-Glaser T, Falko J, Hindman L, La Londe M, Snow R. Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil. 2005 Nov-Dec; 25(6):332-6; quiz 337-8.
Score: 0.003
-
Falko JM, Osei K. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med. 1985 Sep 20; 79(3B):92-101.
Score: 0.003
-
Snow R, LaLonde M, Hindman L, Falko J, Caulin-Glaser T. Independent effect of cardiac rehabilitation on lipids in coronary artery disease. J Cardiopulm Rehabil. 2005 Sep-Oct; 25(5):257-61; quiz 262-3.
Score: 0.003
-
Osei K, Falko JM. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent. Am J Med Sci. 1985 Apr; 289(4):148-53.
Score: 0.002
-
Rudy DR, Falko JM. Osteoporosis in primary care. Ohio State Med J. 1985 Mar; 81(3):208-12.
Score: 0.002
-
Osei K, Falko JM. Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities. Ohio State Med J. 1984 Dec; 80(12):864-9.
Score: 0.002
-
Osei K, O'Dorisio TM, Falko JM. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Am J Med. 1984 Dec; 77(6):1002-9.
Score: 0.002
-
Osei K, Kramer DS, Malarkey WB, Falko JM. Pregnancy complicated by insulinoma. Am J Med Sci. 1984 Oct; 288(3):133-5.
Score: 0.002
-
Bossetti BM, Kocher LM, Moranz JF, Falko JM. The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects. Diabetes Care. 1984 Jul-Aug; 7(4):309-12.
Score: 0.002
-
Falko JM, Maeder MC, Conway C, Mazzaferri EL, Skillman TG. Primary hyperparathyroidism: analysis of 220 patients with special emphasis on familial hypocalciuric hypercalcemia. Heart Lung. 1984 Mar; 13(2):124-31.
Score: 0.002
-
Falko JM, Reynolds JC, O'Dorisio TM, Bossetti B, Cataland S. The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose. Diabetes Care. 1982 Jul-Aug; 5(4):379-85.
Score: 0.002
-
Falko JM, O'Dorisio TM, Cataland S. Spurious elevations in glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia. Arch Intern Med. 1982 Jul; 142(7):1370-1.
Score: 0.002
-
Falko JM, O'Dorisio TM, Cataland S. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA. 1982 Jan 01; 247(1):37-9.
Score: 0.002
-
Zull DN, Falko JM. Metrizamide cisternography in the investigation of the empty sella syndrome. Arch Intern Med. 1981 Mar; 141(4):487-9.
Score: 0.002
-
Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Clin Endocrinol (Oxf). 1980 Dec; 13(6):587-93.
Score: 0.002
-
Falko JM, Schonfeld G, Witztum JL, Kolar JB, Salmon P. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism. 1980 Jul; 29(7):654-61.
Score: 0.002
-
Falko JM, Schonfeld G, Witztum JL, Kolar JB, Weidman SW, Steelman R. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab. 1980 Mar; 50(3):521-8.
Score: 0.002
-
Falko JM, Schonfeld G, Witztum JL, Kolar J, Weidman SW. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia. Metabolism. 1979 Nov; 28(11):1171-7.
Score: 0.002
-
Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med. 1979 Nov; 91(5):750-1.
Score: 0.002
-
Falko JM, Williams JC, Harvey DG, Weidman SW, Schonfeld G, Dodson WE. Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus. J Pediatr. 1979 Oct; 95(4):523-9.
Score: 0.002
-
Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Am J Med. 1979 Feb; 66(2):303-10.
Score: 0.002
-
Sundaram V, Hanna AN, Lubow GP, Koneru L, Falko JM, Sharma HM. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients. Am J Med Sci. 1997 Nov; 314(5):303-10.
Score: 0.001
-
Thomas FB, Sinar D, Caldwell JH, Mekhjian HS, Falko JM. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology. 1977 Aug; 73(2):221-5.
Score: 0.001
-
Falko JM, Guy JT, Smith RE, Mazzaferri EL. Primary hyperparathyroidism and anemia. Arch Intern Med. 1976 Aug; 136(8):887-9.
Score: 0.001
-
Jhiang SM, Fithian L, Weghorst CM, Clark OH, Falko JM, O'Dorisio TM, Mazzaferri EL. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid. 1996 Apr; 6(2):115-21.
Score: 0.001
-
Falko JM, Crockett SE, Cataland S, Mazzaferri EL. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab. 1975 Aug; 41(2):260-5.
Score: 0.001
-
Falko JM, Mekhjian HS, Thomas FB. Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstruction. Am J Dig Dis. 1975 Jun; 20(6):583-87.
Score: 0.001
-
Olmos PR, Falko JM, Rea GL, Boesel CP, Chakeres DW, McGhee DB. Fibrosing pseudotumor of the sella and parasellar area producing hypopituitarism and multiple cranial nerve palsies. Neurosurgery. 1993 Jun; 32(6):1015-21; discussion 1021.
Score: 0.001
-
Bello F, Falko JM, O'Dorisio TM, Osei K. The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patients. Diabet Med. 1991 May; 8(4):385-7.
Score: 0.001
-
Osei K, Falko J, Bossetti BM, Holland GC. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med. 1987 Aug; 83(2):249-55.
Score: 0.001
-
Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab. 1986 Feb; 62(2):325-30.
Score: 0.001
-
Osei K, Falko JM, Fields PG, Bossetti B, O'Dorisio TM. The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients. Diabetologia. 1986 Feb; 29(2):100-5.
Score: 0.001
-
Pariser SF, Stern SL, Shank ML, Falko JM, O'Shaughnessy RW, Friedman CI. Premenstrual syndrome: concerns, controversies, and treatment. Am J Obstet Gynecol. 1985 Nov 15; 153(6):599-604.
Score: 0.001
-
Osei K, Falko JM, O'Dorisio TM, Adam DR. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care. 1985 Sep-Oct; 8(5):436-9.
Score: 0.001
-
Osei K, Falko JM, O'Dorisio TM, Adam DR, Cataland S. Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients. Diabetes Care. 1984 Sep-Oct; 7(5):442-6.
Score: 0.001
-
Osei K, Falko JM, O'Dorisio TM, Adam DR. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care. 1984 Sep-Oct; 7(5):471-5.
Score: 0.001
-
Osei K, Falko JM, Nelson KP, Stephens R. Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med. 1984 Jul; 77(1):41-6.
Score: 0.001
-
Levin P, Falko JM, O'Dorisio TM, Cataland S. Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabetics. Am J Med Sci. 1983 Nov-Dec; 286(3):11-7.
Score: 0.001
-
Bissinger C, Falko JM, Maher W, Rarick M, Cerilli J, Johnson J. Hypertensive crisis induced by eating in a patient with pheochromocytoma. J Clin Gastroenterol. 1983 Apr; 5(2):155-7.
Score: 0.001
-
Hill SA, Falko JM, Wilson CB, Hunt WE. Thyrotrophin-producing pituitary adenomas. J Neurosurg. 1982 Oct; 57(4):515-9.
Score: 0.001
-
Friedman CI, Falko JM, Patel ST, Kim MH, Newman HA, Barrows H. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females. J Clin Endocrinol Metab. 1982 Aug; 55(2):258-62.
Score: 0.001
-
O'Dorisio TM, Falko JM, Cataland S, Almoney RW, George JM, Mazzaferri EL, Reynolds JC. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma. J Clin Endocrinol Metab. 1982 Apr; 54(4):798-802.
Score: 0.001
-
Schear EA, Falko JM, Cataland S, Johnson J, Fanning W. Diabetes insipidus and breast cancer. South Med J. 1982 Mar; 75(3):354-6.
Score: 0.001
-
Abdel-Nabi H, Falko JM, Olsen J. The value of technetium Tc 99m pertechnetate thyroid scanning in the diagnosis of factitious thyrotoxicosis. Arch Intern Med. 1982 Mar; 142(3):644-5.
Score: 0.001
-
Doherty DE, Falko JM, Lefkovitz N, Rogers J, Fromkes J. Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci. 1982 Feb; 27(2):169-70.
Score: 0.000
-
Abdel-Nabi H, Scheu J, Ragosin R, Falko JM, Olsen J. Thyroid uptake of Tc-99m compromising in vivo RBC tagging. J Nucl Med. 1981 Nov; 22(11):1018-9.
Score: 0.000
-
Yovos JG, Falko JM, O'Dorisio TM, Malarkey WB, Cataland S, Capen CC. Thyrotoxicosis and a thyrotropin-secreting pituitary tumor causing unilateral exophthalmos. J Clin Endocrinol Metab. 1981 Aug; 53(2):338-43.
Score: 0.000
-
Pariser SF, Reynolds JC, Falko JM, Jones BA, Mencer DL. Arrhythmia induced by a tricyclic antidepressant in a patient with undiagnosed mitral valve prolapse. Am J Psychiatry. 1981 Apr; 138(4):522-3.
Score: 0.000
-
Levin PA, Falko JM, Dixon K, Gallup EM, Saunders W. Benign parotid enlargement in bulimia. Ann Intern Med. 1980 Dec; 93(6):827-9.
Score: 0.000
-
Weidman SW, Suarez B, Falko JM, Witztum JL, Kolar J, Raben M, Schonfeld G. Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med. 1979 Apr; 93(4):549-69.
Score: 0.000
-
Crockett SE, Cataland S, Falko JM, Mazzaferri EL. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab. 1976 Jun; 42(6):1098-103.
Score: 0.000
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|